Nuvectis Pharma is up a bit on the day, funds flowing in kept the price up 2.90% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. But let's also consider momentum! Nuvectis Pharma has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 255.41 percent which isn't too bad. NVCT might find some support at the 11.85 level, buyers might push the price back up from here. But it's not very clear what will happen.
